Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.06 USD | +4.40% | -2.42% | +31.27% |
May. 15 | Solid Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.27% | 309M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+1.43% | 22.78B | |
-11.04% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- Barclays Adjusts Price Target on Solid Biosciences to $21 From $8, Maintains Overweight Rating